Bridgewater Associates has recently reduced its stake in CVS Health by 3% amid its quarterly dividend announcement while simultaneously increasing its investment in Abbott Laboratories by 11%, signaling a divergence in hedge fund confidence within the healthcare sector. This move reflects broader trends in financial markets, highlighted by a recent tech stock rally driven by upgrades for firms like Meta Platforms and DoorDash, with analysts encouraging strategic buys in a fluctuating investment landscape.
Click a month on the chart to update the report below.